-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zectivimod in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zectivimod in Ulcerative Colitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zectivimod in Ulcerative Colitis Drug Details: Zectivimod is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-20062 in Haemophilus influenzae Type B Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-20062 in Haemophilus influenzae Type B Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-20062 in Haemophilus influenzae Type B Infections Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zectivimod in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zectivimod in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zectivimod in Atopic Dermatitis (Atopic Eczema) Drug Details: Zectivimod...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lifirafenib Maleate in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lifirafenib Maleate in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lifirafenib Maleate in Ovarian Cancer Drug Details: Lifirafenib maleate is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19114 in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19114 in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19114 in Hepatitis B Drug Details: LBVD is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19114 in Poliomyelitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19114 in Poliomyelitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19114 in Poliomyelitis Drug Details: LBVD is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19114 in Pertussis (Whooping Cough)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19114 in Pertussis (Whooping Cough) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19114 in Pertussis (Whooping Cough) Drug Details: LBVD is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19114 in Tetanus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19114 in Tetanus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19114 in Tetanus Drug Details: LBVD is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19114 in Diphtheria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19114 in Diphtheria report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19114 in Diphtheria Drug Details: LBVD is under development for the prevention...
-
Thematic Analysis
NewBatteries in Power – Thematic Intelligence
Battery technology—in the form of a battery energy storage system (BESS)—is scaling up in the power sector due to its economical storage of energy. Storage systems, when integrated with solar or wind energy, can store excessive energy and discharge it as and when required, benefitting the power sector in various ways. BESS deployments are already happening on a very large scale. The battery energy storage market registered a cumulative deployment of 36.7GW at the end of 2023. With growing demand...